Effects of various drugs including organophosphorus compounds (OPC) and therapeutic compounds against OPC on DRL responding

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 4, 1998, Pages 1069-1080

  Bizot, Jean Charles ^a  

^a CENTRE D ETUDES DU BOUCHET   (France)

Author keywords

Acetylcholine; Acetylcholinesterase inhibitors; Benzodiazepine; Muscarinic blockers; Operant behavior; Oximes; Rat; Sarin; Soman

Indexed keywords

ATROPINE; MECAMYLAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; ORGANOPHOSPHORUS COMPOUND; PRALIDOXIME; PYRIMIDOXIME; SARIN; SCOPOLAMINE; SOMAN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; COGNITION; DRUG EFFECT; DRUG INTOXICATION; MALE; MOOD; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOLINERGIC AGENTS; CHOLINESTERASE INHIBITORS; CONDITIONING, OPERANT; MALE; MUSCARINIC ANTAGONISTS; ORGANOPHOSPHORUS COMPOUNDS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; REINFORCEMENT SCHEDULE;

ANIMALIA;

EID: 0032052208     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00519-4     Document Type: Article

References (56)

1. Berz S., Bättig K., Welzl H. The effects of anticholinergic drugs on delayed time discrimination performance in rats. Physiol. Behav. 51:1992;493-499.
2. Bizot J. C., Thiébot M. H., LeBihan C., Soubrié P., Simon P. Effects of imipramine-like drugs and serotonin uptake blockers on delay of reward in rats. Possible implication in the behavioral mechanism of action of antidepressants. J. Pharmacol. Exp. Ther. 246:1988;1144-1151.
3. Brown J. E. Atropine, scopolamine and related antimuscarinic drugs. Goodman Gilman A. G., Rall T. W., Nies A. S., Taylor P. Goodman and Gilman's the phamacological basis of therapeutics. 1990;150-165 Pergamon Press, New York.
4. Callebat, I.: Contribution á l'étude toxicocinétique et métabolique du méthylphosphonofluoridate de triméthyl 1,2,2 propyle (soman) chez le rat. PhD Thesis, University of Paris-Sud; 1990.
5. Clement J. G. Toxicology and pharmacology of bispyridinium oximes - Insight into the mechanism of action vs. soman poisoning in vivo. Fundam. Appl. Toxicol. 1:1981;193-202.
6. Cole B. J., Hillmann M. Effects of benzodiazepine receptor ligands on the performance of an operant delayed matching to position task in rats. Opposite effects of FG 7142 and lorazepam Psychopharmacology (Berlin). 115:1994;350-357.
7. Dawson R. M. Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 14:1994;317-331.
8. Dunnett S. B. Comparative effects of cholinergic drugs and lesions of basalis or fibria-fornix on delayed matching in rats. Psychopharmacology (Berlin). 87:1985;357-363.
9. Duteil J., Rambert F. A., Pessonnier J., Hermant J. F., Gombert R., Assous E. Central alpha1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; Studies with experimental animals. Eur. J. Pharmacol. 180:1990;58-59.
10. 2-agonists and antagonists on timing performance in rats. Pharmacol. Biochem. Behav. 53:1996;759-764.
11. Garrigue, H.: Pharmacocinetique de quelques oximes et leurs interactions avec des récepteurs du système nerveux central de rat. PhD Thesis, University of Montpellier II; 1991.
12. Geller I., Seifter J. The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia. 1:1960;482-492.
13. Haggerty G. C., Kurtz P. J., Armstrong R. D. Duration and intensity of behavioral change after sublethal exposure to soman in rats. Neurobehav. Toxicol. Teratol. 8:1986;695-702.
14. Harris L. W., Stitcher D. L., Heyl W. C. The effects of pretreatments with carbamates, atropine and mecamylamine on survival and on soman-induced alterations in rat and rabbit brain acetylcholine. Life Sci. 26:1980;1885-1891.
15. Herrnstein R. J. Self control as response strength. Bradshaw C. M., Szabadi E., Lowe C. F. Quantification of steady-state operant behaviour. 1981;3-20 Elsevier/North-Holland, Amsterdam.
16. Ho I. K., Hoskins B. Biological and pharmacological aspects of neurotoxicity from and tolerance to organophosphorus cholinesterase inhibitors. Haley T. J., Berndt W. O. Handbook of toxicology. 1987;44-73 Hemisphere Publishing Corp, Washington, DC.
17. Jackson A., Koek W., Colpaert F. C. Can the DRL 72s schedule selectively reveal antidepressant drug activity. Psychopharmacology (Berlin). 117:1995;154-161.
18. Koelega H. S. Stimulant drugs and vigilance performance. A review Psychopharmacology (Berlin). 111:1993;1-16.
19. Lagarde D., Batejat D., Van Beers P., Sarafian D., Pradella S. Interest of modafinil, a new psychostimulant, during a sixty-hour sleep deprivation experiment. Fundam. Clin. Pharmacol. 9:1995;271-279.
20. Landauer M. R., Romano J. A. Acute behavioral toxicity of the organophosphate sarin in rats. Neurobehav. Toxicol. Teratol. 6:1984;239-243.
21. 3H]sarin and its metabolites in mice. Toxicol. Appl. Pharmacol. 83:1986;412-419.
22. Liu W. F., Beaton J. M. The schedule dependent effects of 3-quinuclidinyl benzilate on operant behavior in the rat. Pharmacol. Biochem. Behav. 25:1986;1191-1194.
23. Lundy P. M., Tremblay K. P. Ganglion blocking properties of some bispyridinium soman antagonists. Eur. J. Pharmacol. 60:1979;47-53.
24. Marek G. J., Li A., Seiden L. S. Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72 second schedule. J. Pharmacol. Exp. Ther. 250:1989;52-59.
25. Maricq A. V., Church R. The differential effects of haloperidol and methamphetamine on time estimation in the rat. Psychopharmacology (Belrin). 79:1983;10-15.
26. McCloskey T. C., Paul B. K., Commissaris R. L. Buspirone effects in an animal conflict procedure. Comparison with diazepam and phenobarbital Pharmacol. Biochem. Behav. 27:1987;171-175.
27. McDonough J. H., Smith R. F., Smith C. D. Behavioral correlates of soman-induced neuropathology. Deficits in DRL acquisition Neurobehav. Toxicol. Teratol. 8:1986;179-187.
28. McGuire P. S., Seiden L. S. The effects of tricyclic antidepressants on performance under a differential-reinforcement-of-low-rates schedule in rats. J. Pharmacol. Exp. Ther. 214:1980;635-641.
29. Meck W. H. Neuropharmacology of timing and time perception. Cogn. Brain Res. 3:1996;227-242.
30. Morrisson C. F. The effects of nicotine on punished behaviour. Psychopharmacologia. 14:1969;221-232.
31. Nieminen S. A., Lecklin A., Heikkinen O., Ylitalo P. Acute behavioural effects of the organophosphates sarin and soman in rats. Pharmacol. Toxicol. 67:1990;36-40.
32. O'Donnell J. M., Seiden L. S. Differential-reinforcement-of-low-rate 72-second schedule. Selective effects of antidepressant drugs J. Pharmacol. Exp. Ther. 224:1983;80-88.
33. Pollard G. T., Howard J. L. Similar effects of antidepressant and nonantidepressant drugs on behavior under an interresponse-time > 72-s schedule. Psychopharmacology (Berlin). 89:1986;253-258.
34. Reynolds M. L., Little P. J., Thomas B. F., Bagley R. B., Martin B. R. Relationship between the biodisposition of [H3]soman and its pharmacological effects in mice. Toxicol. Appl. Pharmacol. 80:1985;409-420.
35. Russell R. W., Booth R. A., Lauretz S. D., Smith C. A., Jenden D. J. Behavioral, neurochemical and physiological effects of repeated exposures to subsymptomatic levels of the anticholinesterase, soman. Neurobehav. Toxicol. Teratol. 8:1986;675-685.
36. Sabol R. E., Richard J. B., Layton K., Seiden L. S. Amphetamine analogs have differential effects on DRL36-s schedule performance. Psychopharmacology (Berlin). 121:1995;57-65.
37. Salmon P., Gray J. F. Comparison between the effects of propranolol and chlordiazepoxide on timing behaviour in the rat. Psychopharmacology (Berlin). 87:1985;219-224.
38. Sanger D. J. The alpha2-adrenoceptor antagonists idazoxan and yohimbine increase rates of DRL responding in rats. Psychopharmacology (Berlin). 95:1988;413-417.
39. Sanger D. J. NMDA antagonists disrupt timing behaviour in rats. Behav. Pharmacol. 3:1992;593-600.
40. Sanger D. J., Blackman D. E. The effects of tranquilizing drugs on timing behaviour in rats. Psychopharmacologia. 44:1975;153-156.
41. Sanger D. J., Key M., Blackman D. E. Differential effects of chlordiazepoxide and d-amphetamine on responding maintained by a DRL schedule of reinforcement. Psychopharmacologia. 38:1974;159-171.
42. Shih T. M., Whalley C. E., Valdes J. J. A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning. Toxicol. Lett. 55:1991;131-147.
43. Shurtleff D., Raslear T. G., Genovese R. F., Simmons L. Perceptual bisection in rats. The effects of physostigmine, scopolamine and pirenzepine Physiol. Behav. 51:1992;381-390.
44. Simon P. H., Panissaud C. H., Costentin J. The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. Psychopharmacology (Berlin). 114:1994;597-600.
45. Soffie M., Lejeune H. Cholinergic blockade and response timing in rats. Psychopharmacology (Berlin). 106:1992;215-220.
46. Somani S. M., Dube S. N. Physostigmine - An overview as pretreatment drug for organophosphate intoxication. Int. J. Clin. Pharmacol. Ther. Toxicol. 27:1989;367-387.
47. Stephens D. N., Cole B. J. AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks. Psychopharmacology (Berlin). 126:1996;249-259.
48. Stephens D. N., Voet B. Differential effect of anxiolytic and nonanxiolytic benzodiazepine receptor ligands on performance of a differential reinforcement of low rate (DRL) schedule. Behav. Pharmacol. 5:1994;4-14.
49. Tanganelli S., Perez de la Mora M., Ferraro L., Méndez-Franco J., Beani L., Rambert F. A., Fuxe K. Modafinil and cortical gamma-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins. Eur. J. Pharmacol. 273:1995;63-71.
50. Taylor P. Anticholinesterase agents. Goodman Gilman A. G., Rall T. W., Nies A. S., Taylor P. Goodman and Gilman's the phamacological basis of therapeutics. 1990;131-149 Pergamon Press, New York.
51. Thiébot M. H., Dangoumau L., Richard G., Puech A. J. Safety signal withdrawal. A behavioural paradigm sensitive to both "anxiolytic" and "anxiogenic" drugs under identical experimental conditions Psychopharmacology (Berlin). 103:1991;415-424.
52. Thiébot M. H., LeBihan C., Soubrié P., Simon P. Benzodiazepines reduce the tolerance to reward delay in rats. Psychopharmacology (Berlin). 86:1985;147-152.
53. Thiébot M. H., Soubrié P., Simon P. Is delay of reward mediated by shock-avoidance behavior a critical target for anti-punishment effects of diazepam in rats? Psychopharmacology (Berlin). 87:1985;473-479.
54. Vogel J. R., Beer B., Clody D. E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia. 21:1971;1-7.
55. Wiley J. A., Balster R. L. Preclinical evaluation of N-Methyl-D-Aspartate antagonists for antianxiety effects. A review Kamenka J. M., Domino E. F. Multiple sigma and PCP receptor ligands. Mechanisms for neuromodulation and neuroprotection? 1992;801-815 NPP Books, Ann Arbor, MI.
56. Wolthuis O. L., Vanwersch R. A. P. Behavioral changes in the rat after low doses of cholinesterase inhibitors. Fundam. Appl. Toxicol. 4:1984;S195-S208.